Dr Maria Alice Franzoi, medical oncologist and specialist in digital health and care pathway implementation, will present the results of the HOPE study at the ESMO Congress. This...

Dr Joana Ribeiro, medical oncologist in the Drug Development Department at Gustave Roussy, will present the results of the POP-DURVA clinical trial at the ESMO Congress. Conducted within...

The Interception program has reached a new milestone with the enrollment of its first patients as part of the national Article 51 pilot program. Rolled out over four years across seven...

Gustave Roussy is launching a new care pathway designed to accelerate the management of women recently diagnosed with breast cancer. It brings together, in a single day, the radiology...

Two of Gustave Roussy’s four new medical and scientific programmes are dedicated to childhood cancers. The first, DECRIPT, aims to improve understanding of the role played by genetics in...

By order of Ms. Stéphanie Rist, Minister of Health, Families, Autonomy and Persons with Disabilities, dated 27 July 2026, Professor Fabrice Barlesi has been reappointed as Director...

For the Route du Rhum - Destination Guadeloupe 2026, Jean Le Cam and Christophe Rateau will sail under the colors of Gustave Roussy, the leading cancer center in France and Europe...

Owkin and Gustave Roussy, Europe's leading cancer center, today announced a partnership to test K Pro directly within the hospital's real-world clinical and research workflows.